An ISOPP Education Program on Oncology Pharmacotherapy and Applications of Biosimilars is coming in 2021!

The International Society of Oncology Pharmacy Practitioners (ISOPP) is delighted to introduce a virtual education program on Oncology Pharmacotherapy and Applications of Biosimilars in 2021. 

Recognizing that there is a rapid expansion of Biosimilars usage in clinical practice, and that the role of an oncology pharmacist is evolving and further integrating as a key member of a multidisciplinary healthcare team, ISOPP is developing an online education program that supports oncology pharmacists to safely and confidently introduce Biosimilars into their clinical practice and multidisciplinary healthcare team. ISOPP will present this education program in a novel way by giving both fundamentals and advanced aspects of 1) pharmacotherapy of various cancers, 2) implementation of biosimilars in oncology practice and 3) interpretation of available scientific and regulatory data and pharmacist’s recommendations for using biosimilars in different cancers. 

This initiative is being supported by Pfizer through an educational grant.

The education program is aimed at ISOPP Members who are oncology pharmacists and have practiced for at least one year in the area of oncology pharmacy. 

The program will launch in 2021 and will consist of 10 online courses (25 hours) and an opportunity to meet at ISOPP’s 2022 Symposium in Spain to expand the Biosimilars Expert Network.  

I very much look forward to sharing the program details with you in the coming months. Stay tuned! 

Regards,

Himanshu Patel
ISOPP Education Committee Chair 
education@isopp.org

 

 
Tags: